XBiotech (XBIT) Change in Cash (2014 - 2025)
XBiotech (XBIT) posted quarterly Change in Cash of -$21.8 million for Q4 2025, down 108.95% year-over-year from $243.9 million in Q4 2024, and down 291.6% quarter-over-quarter from -$5.6 million in Q3 2025.
XBiotech (XBIT) Change in Cash (2014 - 2025) Analysis & Trends
XBiotech's Change in Cash history runs 12 years deep, the most recent figure standing at -$21.8 million for Q4 2025.
- In Q4 2025, Change in Cash fell 108.95% year-over-year to -$21.8 million; the TTM figure through Dec 2025 stood at -$47.1 million (down 72.33% YoY), while the FY2025 annual figure was -$47.1 million, down 72.33% from the prior year.
- Change in Cash for Q4 2025 stood at -$21.8 million, down from -$5.6 million in the prior quarter.
- The five-year high for Change in Cash was $75.4 million in Q2 2021, with the low at -$76.4 million in Q3 2021.
- The 5-year median for Change in Cash is -$5.3 million (2022), against an average of -$5.6 million.
- The sharpest annual moves came in 2021 and 2025: Change in Cash soared 736.81% in 2021, then plunged 1751.57% in 2025.
- XBiotech's Change in Cash stood at -$1.9 million in 2021, then slumped by 72.23% to -$3.3 million in 2022, then soared by 33.54% to -$2.2 million in 2023, then sank by 381.6% to -$10.4 million in 2024, then sank by 108.95% to -$21.8 million in 2025.
- Business Quant data shows XBIT's Change in Cash at -$21.8 million in Q4 2025, -$5.6 million in Q3 2025, and -$3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.82 Mn |
| Sep 30, 2025 | -5.57 Mn |
| Jun 30, 2025 | -2.96 Mn |
| Mar 31, 2025 | -16.78 Mn |
| Dec 31, 2024 | -10.44 Mn |
| Sep 30, 2024 | -5.41 Mn |
| Jun 30, 2024 | -12.51 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | -2.17 Mn |
| Sep 30, 2023 | 58.80 Mn |
| Jun 30, 2023 | -9.09 Mn |
| Mar 31, 2023 | -4.82 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -65.23 Mn |
| Jun 30, 2022 | -6.03 Mn |
| Mar 31, 2022 | -5.16 Mn |
| Dec 31, 2021 | -1.89 Mn |
| Sep 30, 2021 | -76.38 Mn |
| Jun 30, 2021 | 75.38 Mn |
| Mar 31, 2021 | 2.51 Mn |